(Q41532868)

English

Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies?

scientific article published on May 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

Europe PubMed Central

Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: what can we learn from small studies? (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Evans WE

1

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Relling MV

2

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Boyett JM

3

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Pui CH

4

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Leukemia Research

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

435-437

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MTX clearance is more important for intermediate-risk ALL.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical aspects of prognostic factor studies in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient characteristics associated with high-risk methotrexate concentrations and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the automatic interaction detector method to identify patient characteristics related to methotrexate clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Childhood leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900128-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(96)00128-2

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41532868&oldid=2143639883"